Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is a GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management
Tirzepatide 30mg (30mg/vial) starts at $120.99 per vial
Additionally, the region is witnessing strategic collaborations between global pharmaceutical companies and local firms, along with government initiatives to manage lifestyle diseases, which collectively drive strong demand for oral GLP-1 treatments across Asia-Pacific
Challenges and Side Effects Side Effects Experienced The interviewees experienced mild side effects like bloating, breast tenderness, nausea and mood swings
Zepbound activates both GIP and GLP-1 receptors, meaning it has a dual mechanism of action, compared to semaglutide and orforglipron, which only activate GLP-1 receptors
Raakesh is a Science Graduate with Masters in Business Administration and is passionate about keeping himself up-to-date with the latest in the field of medical and pharmaceutical research
US$ 26.28
US$ 21.23
US$ 29.74
US$ 25.79
US$ 28.39
